V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 180012117 | 180001553 | null | null | Curative (C) | null | 2017-03-31 | null | null | null | SELPERCATINIB | 101771415 |
| 180012160 | 180001560 | null | null | null | null | 2020-01-12 | null | null | null | CARBOPLATIN + LIPOSOMAL DOX | 101544286 |
| 180012170 | 180001561 | null | null | null | null | 2016-08-23 | null | null | null | CISPLATIN + DOXORUBICIN | 101822386 |
| 180012199 | 180001565 | null | null | Palliative (P) | null | 2019-07-03 | null | null | null | WT SIOP 2002 01 POST OP CARBO, ETOP | 101647310 |
| 180012207 | 180001567 | null | null | Palliative (P) | null | 2016-09-02 | null | null | null | PALBOCICLIB | 101697994 |
| 180012263 | 180001573 | null | null | null | null | 2019-12-30 | null | null | null | NB LOW/INTERM RISK GUIDELINES CARBO/ETOP | 101162720 |
| 180012337 | 180001579 | null | null | Neo-adjuvant (N) | null | 2019-07-10 | null | null | null | RITUXIMAB | 101405279 |
| 180012367 | 180001581 | null | null | null | null | 2012-05-23 | null | null | null | CISPLATIN + DOXORUBICIN + ETOPOSIDE + MITOTANE | 100785100 |
| 180012427 | 180001585 | null | null | null | null | 2018-09-09 | null | null | null | CISPLATIN + GEMCITABINE | 100802350 |
| 180012528 | 180001593 | null | null | Adjuvant (A) | null | 2017-07-07 | null | null | null | BENDAMUSTINE + RITUXIMAB | 100297376 |
| 180012537 | 180001594 | null | null | null | null | 2018-10-23 | null | null | null | SELPERCATINIB | 101156113 |
| 180012541 | 180001595 | null | null | null | null | 2020-02-27 | null | null | null | IXAZOMIB + LENALIDOMIDE | 101106401 |
| 180012566 | 180001597 | null | null | Curative (C) | null | 2021-12-19 | null | null | null | HYDROXYCARBAMIDE | 100833094 |
| 180012588 | 180001601 | null | null | null | null | 2017-12-17 | null | null | null | SORAFENIB | 100117782 |
| 180012595 | 180001603 | null | null | Adjuvant (A) | null | 2016-10-29 | null | null | null | CISPLATIN | 101842314 |
| 180012596 | 180001604 | null | null | null | null | 2017-08-10 | null | null | null | MITOTANE | 101425806 |
| 180012624 | 180001609 | null | null | Curative (C) | null | 2021-04-26 | null | null | null | MITOTANE | 100889058 |
| 180012667 | 180001615 | null | null | Curative (C) | null | 2017-11-09 | null | null | null | NOT MATCHED | 101240113 |
| 180012727 | 180001622 | null | null | null | null | 2019-01-11 | null | null | null | NOT MATCHED | 101775830 |
| 180012733 | 180001623 | null | null | null | null | 2017-05-02 | null | null | null | IMATINIB | 100941885 |
| 180012781 | 180001628 | null | null | null | null | 2017-12-12 | null | null | null | CNS GCT II GERMINOMA - CARBO ETOP | 101143357 |
| 180012828 | 180001631 | null | null | null | null | 2021-07-24 | null | null | null | NB LOW/INTERM RISK GUIDELINES CARBO/ETOP | 101077092 |
| 180012846 | 180001633 | null | null | null | null | 2017-08-22 | null | null | null | CISPLATIN | 100244149 |
| 180012849 | 180001634 | null | null | null | null | 2019-09-18 | null | null | null | CVD (NEUROENDOCRINE) | 100701981 |
| 180012861 | 180001635 | null | null | null | null | 2017-05-03 | null | null | null | SORAFENIB | 101155435 |
| 180012864 | 180001636 | null | null | null | null | 2018-07-16 | null | null | null | CISPLATIN + GEMCITABINE + RITUXIMAB | 100645372 |
| 180012962 | 180001647 | null | null | null | null | 2017-04-08 | null | null | null | CISPLATIN + ETOPOSIDE | 101031646 |
| 180012969 | 180001649 | null | null | Neo-adjuvant (N) | null | 2016-10-04 | null | null | null | HYDROXYCARBAMIDE | 100292945 |
| 180012971 | 180001650 | null | null | null | null | 2017-03-06 | null | null | null | CARBOPLATIN + ETOPOSIDE | 101136243 |
| 180012978 | 180001651 | null | null | null | null | 2016-09-29 | null | null | null | LENVATINIB | 101626024 |
| 180012992 | 180001652 | null | null | null | null | 2017-05-18 | null | null | null | NB HRNBL-1 COJEC IND COURSE A | 100995135 |
| 180013013 | 180001654 | null | null | null | null | 2017-05-20 | null | null | null | CABOZANTINIB | 101056671 |
| 180013089 | 180001663 | null | null | null | null | 2019-03-08 | null | null | null | CISPLATIN + DOXORUBICIN + ETOPOSIDE + MITOTANE | 100101985 |
| 180013168 | 180001672 | null | null | null | null | 2019-11-12 | null | null | null | SORAFENIB | 100047472 |
| 180013192 | 180001677 | null | null | null | null | 2016-07-08 | null | null | null | NB LOW/INTERM RISK GUIDELINES CARBO/ETOP | 101242523 |
| 180013211 | 180001678 | null | null | null | null | 2017-10-31 | null | null | null | CARBOPLATIN + PACLITAXEL | 101418833 |
| 180013268 | 180001686 | null | null | null | null | 2019-07-23 | null | null | null | MITOTANE | 100392361 |
| 180013269 | 180001687 | null | null | Curative (C) | null | 2017-10-08 | null | null | null | DOCETAXEL | 101296299 |
| 180013322 | 180001693 | null | null | null | null | 2018-08-22 | null | null | null | IPILIMUMAB + NIVOLUMAB | 100503947 |
| 180013364 | 180001697 | null | null | null | null | 2020-04-09 | null | null | null | STREPTOZOCIN | 100337036 |
| 180013420 | 180001701 | null | null | null | null | 2016-12-03 | null | null | null | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 101241966 |
| 180013493 | 180001708 | null | null | Curative (C) | null | 2018-09-18 | null | null | null | CISPLATIN + DOXORUBICIN + ETOPOSIDE | 101442693 |
| 180013504 | 180001710 | null | null | null | null | 2022-04-26 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100925859 |
| 180013515 | 180001712 | null | null | Curative (C) | null | 2018-07-06 | null | null | null | LETROZOLE + PALBOCICLIB | 101753703 |
| 180000023 | 180001714 | null | null | null | null | 2020-05-22 | null | null | null | CISPLATIN + DOXORUBICIN + ETOPOSIDE + MITOTANE | 100684456 |
| 180000146 | 180001716 | null | null | null | null | 2020-06-24 | null | null | null | CVP R | 100641537 |
| 180000148 | 180001717 | null | null | null | null | 2014-11-20 | null | null | null | HYDROXYCARBAMIDE | 101619404 |
| 180000653 | 180001721 | null | null | null | null | 2019-06-18 | null | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101474349 |
| 180000964 | 180001722 | null | null | null | null | 2021-04-15 | null | null | null | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100260458 |
| 180001245 | 180001724 | null | null | Neo-adjuvant (N) | null | 2018-08-13 | null | null | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100848886 |